Search

everythinglearnresearchcommunity

for

Search:↓

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Blocking LFA-1 prevents hair loss in mice.

A certain genetic variation in the IL1A gene may lower the risk of a hair loss condition in Chinese people.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Belimumab effectively reduces disease activity in lupus patients, regardless of initial serologic status.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

RNase L hinders hair follicle regeneration by altering immune signals.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

Blocking IL-17 can reduce joint inflammation in Ross River Virus infections.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.